Overview

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Status:
Completed
Trial end date:
2013-10-17
Target enrollment:
Participant gender:
Summary
This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) in people with coronary heart disease.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Darapladib